Octreotide Reference
Educational, not medical advice reference for Octreotide: Hormonal; regulatory status, evidence posture, source review, and schedule notes. Also…
Plain English
- What it is
- Octreotide (brand names Sandostatin and Sandostatin LAR) is an FDA-approved prescription medicine given by a doctor. It is a man-made copy of a natural body hormone called somatostatin.
- What people use it for
- Doctors prescribe it for acromegaly, a condition where the body makes too much growth hormone. It is also used to ease severe diarrhea and flushing caused by certain rare hormone-producing tumors known as carcinoid tumors and VIPomas.
- What the science shows
- This is a label-verified medicine with decades of approved use in hormone and tumor-related care. The supporting evidence comes from its official FDA prescribing information.
- The catch
- Long-term use can lead to gallbladder problems such as gallstones, and it can change blood sugar levels and slow the heart rate. It is a prescription medicine that needs a doctor's oversight, not something to use on your own.
Reference summary
Octreotide is a label-verified somatostatin analog with decades of approved-label endocrine-oncology evidence. pepSmart surfaces label-reference content only.
Regulatory and posture
- Categories
- Hormonal
- Aliases
- Sandostatin, Sandostatin LAR, Somatostatin analog
- Evidence posture
- human
- Regulatory status
- FDA-approved prescription medication. Labeled uses include acromegaly, carcinoid-syndrome symptoms, and VIPoma-related watery diarrhea. Immediate-release (Sandostatin) and long-acting depot (Sandostatin LAR) are separate label products.
- Content review status
- label verified
Selected public sources
Related tools
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.
For research and educational purposes only. Not medical advice.